C
OMGA

Certuity’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Certuity’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,000
Closed -$14.9K – 433
2024
Q4 		$14.9K Buy
20,000
+5,000
+33% +$4.98K ﹤0.01% 380
2024
Q3 		$18.3K Buy
15,000
+5,000
+50% +$7.96K ﹤0.01% 354
2024
Q2 		$20.7K Buy
+10,000
New +$23.6K ﹤0.01% 353

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Certuity's OMGA Position: Q1 2025 in Review

Certuity sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 20,000 shares — an estimated $14.9K sold.

Certuity first reported a position in OMGA in Q2 2024 and held it in 3 quarters. The position peaked at $20.7K in Q2 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Certuity reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Certuity sold 20,000 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $14.9K.
  • Certuity first reported a position in Omega Therapeutics, Inc. Common Stock in Q2 2024 and held it in 3 quarters.
  • Certuity's Omega Therapeutics, Inc. Common Stock position peaked at $20.7K in Q2 2024.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Certuity's 13F filing for Q1 2025, filed 13 May 2025.